Andrea Abbott

Concepts (208)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
12
2021
1533
1.810
Why?
Melanoma
5
2020
335
1.460
Why?
Carcinoma, Intraductal, Noninfiltrating
4
2021
32
1.420
Why?
Skin Neoplasms
5
2020
375
1.400
Why?
Mastectomy, Segmental
8
2021
63
1.340
Why?
Carcinoma, Ductal, Breast
5
2021
61
1.220
Why?
Liver Neoplasms
3
2018
334
1.200
Why?
Yttrium Radioisotopes
2
2018
4
1.190
Why?
Embolization, Therapeutic
2
2018
150
1.000
Why?
Surgical Procedures, Operative
1
2021
124
0.770
Why?
Workplace
1
2020
75
0.730
Why?
Neoplasm Recurrence, Local
4
2016
444
0.720
Why?
Burnout, Professional
1
2020
64
0.710
Why?
Intraoperative Care
3
2016
91
0.690
Why?
Drug Prescriptions
1
2020
135
0.680
Why?
Uveal Neoplasms
1
2018
16
0.660
Why?
Pain, Postoperative
1
2020
214
0.650
Why?
Internship and Residency
2
2022
596
0.640
Why?
Pandemics
1
2021
346
0.640
Why?
Mastectomy
2
2021
56
0.610
Why?
Lymph Node Excision
3
2017
91
0.590
Why?
Physicians
1
2020
324
0.580
Why?
Prognosis
9
2021
2093
0.570
Why?
Health Promotion
1
2020
407
0.570
Why?
Opioid-Related Disorders
1
2020
298
0.560
Why?
Middle Aged
23
2021
21119
0.530
Why?
Radiotherapy
2
2016
86
0.520
Why?
Aged
21
2021
14842
0.520
Why?
Aged, 80 and over
11
2021
4843
0.520
Why?
Analgesics, Opioid
1
2020
498
0.520
Why?
Retrospective Studies
16
2021
7264
0.520
Why?
Length of Stay
5
2017
780
0.500
Why?
Carcinoma
1
2015
215
0.470
Why?
Brachytherapy
1
2013
79
0.460
Why?
Colorectal Neoplasms
2
2016
560
0.450
Why?
Female
25
2021
38015
0.440
Why?
Anus Neoplasms
1
2012
13
0.440
Why?
Electrocoagulation
1
2012
34
0.420
Why?
Retroperitoneal Neoplasms
1
2012
12
0.420
Why?
Surgical Wound Infection
2
2017
168
0.420
Why?
Mammaplasty
1
2012
41
0.410
Why?
Sarcoma
1
2012
70
0.400
Why?
Anesthetics, Local
1
2012
83
0.400
Why?
Hospital Mortality
1
2012
384
0.380
Why?
Humans
28
2022
68525
0.380
Why?
Colonic Neoplasms
1
2012
299
0.360
Why?
Postoperative Complications
3
2017
1615
0.340
Why?
Age Factors
4
2021
1860
0.340
Why?
Adult
14
2021
21375
0.320
Why?
Neoplasm Staging
5
2018
799
0.290
Why?
Perception
2
2020
189
0.290
Why?
Robotic Surgical Procedures
2
2017
49
0.270
Why?
Survival Rate
3
2018
1055
0.260
Why?
Tertiary Care Centers
2
2021
67
0.240
Why?
Neoplasm, Residual
2
2021
33
0.240
Why?
Adenocarcinoma
2
2017
475
0.230
Why?
Male
13
2021
37281
0.230
Why?
Lymphatic Metastasis
2
2020
274
0.210
Why?
Perioperative Period
1
2021
24
0.210
Why?
Clinical Clerkship
1
2022
63
0.210
Why?
Young Adult
4
2021
5708
0.210
Why?
Sentinel Lymph Node Biopsy
3
2020
53
0.200
Why?
Elective Surgical Procedures
1
2021
95
0.200
Why?
Treatment Outcome
5
2018
7028
0.190
Why?
Waste Management
1
2020
11
0.190
Why?
Time-to-Treatment
1
2021
117
0.190
Why?
Mitosis
1
2020
76
0.180
Why?
Follow-Up Studies
3
2018
3256
0.180
Why?
Students, Medical
1
2022
210
0.180
Why?
Operative Time
3
2017
45
0.180
Why?
General Surgery
1
2020
95
0.180
Why?
Reoperation
1
2021
467
0.180
Why?
Carcinoma, Lobular
2
2016
20
0.170
Why?
Patient Satisfaction
1
2021
378
0.170
Why?
Time Factors
4
2015
4655
0.160
Why?
Radiotherapy, Adjuvant
2
2016
125
0.160
Why?
Anxiety
1
2021
422
0.160
Why?
Feasibility Studies
1
2020
652
0.160
Why?
Receptors, Estrogen
1
2018
142
0.160
Why?
Glycation End Products, Advanced
1
2018
125
0.160
Why?
Patient Education as Topic
1
2020
424
0.150
Why?
Lymph Nodes
2
2017
258
0.150
Why?
Radiotherapy Dosage
2
2016
125
0.150
Why?
Skin
1
2020
451
0.150
Why?
Esophagectomy
1
2017
26
0.150
Why?
Glucose Transporter Type 1
1
2016
18
0.150
Why?
DNA Polymerase II
1
2016
5
0.140
Why?
F-Box Proteins
1
2016
14
0.140
Why?
Life Style
1
2018
338
0.140
Why?
Quality Improvement
1
2020
413
0.140
Why?
Proportional Hazards Models
2
2016
791
0.140
Why?
SEER Program
2
2020
150
0.140
Why?
Esophageal Neoplasms
1
2017
150
0.140
Why?
Ubiquitin-Protein Ligases
1
2016
89
0.140
Why?
Surveys and Questionnaires
2
2021
2798
0.130
Why?
Patient Selection
2
2016
592
0.130
Why?
Axilla
1
2015
36
0.130
Why?
Choristoma
1
2015
20
0.130
Why?
Rose Bengal
1
2014
3
0.130
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2014
2
0.130
Why?
BCG Vaccine
1
2014
12
0.130
Why?
Injections, Intralesional
1
2014
25
0.130
Why?
Disease Progression
1
2018
1037
0.130
Why?
Adjuvants, Immunologic
1
2014
63
0.120
Why?
Antineoplastic Agents, Alkylating
1
2014
57
0.120
Why?
United States
4
2022
7335
0.120
Why?
Survival Analysis
2
2016
714
0.120
Why?
Cell Cycle Proteins
1
2016
230
0.120
Why?
Breast
1
2015
137
0.120
Why?
Iridium Radioisotopes
1
2013
11
0.120
Why?
Patient Readmission
2
2017
267
0.120
Why?
Interleukin-2
1
2014
133
0.120
Why?
Immunologic Factors
1
2014
87
0.120
Why?
Laparoscopy
1
2016
237
0.120
Why?
Multivariate Analysis
2
2016
1046
0.120
Why?
Neoplasms, Second Primary
1
2013
61
0.110
Why?
Quality of Life
1
2021
1515
0.110
Why?
Adolescent
4
2020
8903
0.110
Why?
Pancreatic Neoplasms
1
2016
332
0.110
Why?
Inguinal Canal
1
2012
5
0.110
Why?
Surgical Wound Dehiscence
1
2012
20
0.110
Why?
Genetic Therapy
1
2014
291
0.110
Why?
Hepatectomy
1
2012
58
0.110
Why?
Confidence Intervals
1
2012
242
0.110
Why?
Colectomy
1
2012
64
0.110
Why?
Lidocaine
1
2012
36
0.110
Why?
Camping
1
2011
6
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2016
756
0.100
Why?
Practice Patterns, Physicians'
1
2016
503
0.100
Why?
Minimally Invasive Surgical Procedures
1
2012
85
0.100
Why?
Epinephrine
1
2012
103
0.100
Why?
Fires
1
2011
21
0.100
Why?
Statistics, Nonparametric
1
2012
306
0.100
Why?
Bronchodilator Agents
1
2012
43
0.100
Why?
Carcinoma, Squamous Cell
1
2017
624
0.100
Why?
Cohort Studies
3
2016
2356
0.100
Why?
Prospective Studies
3
2015
3702
0.100
Why?
Chi-Square Distribution
1
2012
546
0.100
Why?
Surgical Flaps
1
2012
120
0.100
Why?
Neoplasm Invasiveness
1
2012
369
0.100
Why?
Peritoneal Neoplasms
1
2010
23
0.090
Why?
Mesothelioma
1
2010
21
0.090
Why?
Burns
1
2011
83
0.090
Why?
Gastrointestinal Neoplasms
1
2010
40
0.090
Why?
Water-Electrolyte Imbalance
1
2010
29
0.090
Why?
Odds Ratio
1
2012
880
0.090
Why?
Hyperthermia, Induced
1
2010
53
0.090
Why?
Preoperative Care
1
2011
275
0.090
Why?
Obesity
1
2017
1074
0.090
Why?
Sentinel Lymph Node
2
2020
4
0.080
Why?
Pediatrics
1
2011
341
0.080
Why?
Sex Factors
1
2012
1265
0.080
Why?
Antineoplastic Agents
1
2015
1070
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
467
0.070
Why?
Risk Factors
2
2018
5719
0.070
Why?
Tumor Burden
2
2017
132
0.070
Why?
Combined Modality Therapy
2
2018
951
0.050
Why?
Magnetic Resonance Imaging
1
2011
2222
0.050
Why?
Risk Assessment
2
2020
2004
0.050
Why?
Schools, Medical
1
2022
157
0.050
Why?
Educational Measurement
1
2022
254
0.050
Why?
Kaplan-Meier Estimate
1
2020
536
0.040
Why?
Neoplasm Grading
1
2018
110
0.040
Why?
Tamoxifen
1
2018
62
0.040
Why?
Antineoplastic Agents, Hormonal
1
2018
99
0.040
Why?
Anastomotic Leak
1
2017
11
0.040
Why?
Hospitals, High-Volume
1
2017
18
0.040
Why?
Learning Curve
1
2016
20
0.040
Why?
F-Box-WD Repeat-Containing Protein 7
1
2016
1
0.040
Why?
Poly-ADP-Ribose Binding Proteins
1
2016
7
0.040
Why?
Equipment Failure
1
2016
112
0.040
Why?
Blood Loss, Surgical
1
2017
79
0.040
Why?
Cancer Survivors
1
2018
145
0.040
Why?
Drug Resistance, Neoplasm
1
2018
332
0.040
Why?
Florida
1
2016
221
0.040
Why?
Fluorodeoxyglucose F18
1
2016
81
0.030
Why?
Medical Errors
1
2016
80
0.030
Why?
Pelvis
1
2016
38
0.030
Why?
Pneumonia
1
2017
110
0.030
Why?
Venous Thrombosis
1
2017
124
0.030
Why?
Canada
1
2016
266
0.030
Why?
Positron-Emission Tomography
1
2016
160
0.030
Why?
Prophylactic Surgical Procedures
1
2015
2
0.030
Why?
Disease-Free Survival
1
2016
349
0.030
Why?
Overweight
1
2017
186
0.030
Why?
Preoperative Period
1
2015
50
0.030
Why?
Postoperative Period
1
2015
238
0.030
Why?
Pulmonary Embolism
1
2017
253
0.030
Why?
Cell Line, Tumor
1
2018
1849
0.030
Why?
Body Mass Index
1
2017
866
0.030
Why?
Biomarkers
1
2018
1593
0.030
Why?
Registries
1
2016
730
0.030
Why?
Comorbidity
1
2017
1425
0.030
Why?
RNA, Messenger
1
2016
1663
0.030
Why?
Incidence
1
2016
1582
0.030
Why?
Longitudinal Studies
1
2015
1054
0.030
Why?
Health Status Indicators
1
2011
117
0.020
Why?
Mutation
1
2016
1213
0.020
Why?
Organoplatinum Compounds
1
2010
21
0.020
Why?
Mitomycin
1
2010
27
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
26
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
58
0.020
Why?
Cardiovascular Diseases
1
2017
938
0.020
Why?
Signal Transduction
1
2018
2688
0.020
Why?
Hospitalization
1
2011
977
0.020
Why?
Infant
1
2011
2891
0.020
Why?
Child, Preschool
1
2011
3185
0.020
Why?
Child
1
2011
6400
0.010
Why?
Abbott's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (208)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_